Latest filing published 03 Feb 2026 for Atea Pharmaceuticals, Inc.. Read the official filing
No signal scores available.
All filings by Janet MJ Hammond on record concern Atea Pharmaceuticals, Inc. Between 31 January 2024 and 31 January 2026, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 3 February 2026 with an option exercise in Atea Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations